CAPE TOWN (Reuters) – Developing new front-line antiretroviral (ARV) drugs and using technology for early diagnosis are among key steps needed to sustain momentum in fighting HIV/Aids and ending the disease as a public health threat by 2030, UNAIDS said in a r... More »
By Lisa Rapaport(Reuters Health) – Many patients with peripheral artery disease, a common cause of chronic disability and mobility limitations in the More »
By Andrew M. Seaman(Reuters Health) – In general, childhood cancer survivors are just as satisfied with their sex lives as people who didn’t have ca More »
Israeli biotech firm Pluristem Therapeutics said it hopes its anti-radiation therapy will protect Fukushima workers decommissioning nuclear reactors and save lives in the future if ever a similar catastrophe occurs. The Haifa-based company said they have devel... More »
